Status:
RECRUITING
Accurate, Rapid and Inexpensive MRI Protocol for Breast Cancer Screening
Lead Sponsor:
University of Chicago
Conditions:
Breast Cancer
Eligibility:
FEMALE
40-74 years
Brief Summary
The purpose of this study is to test an innovative MRI breast cancer screening method in women with mammographically dense breasts as well as other women with moderately increased cancer risk. MRI, co...
Eligibility Criteria
Inclusion
- Women that have had a mammographically and/or sonographically identified finding that will require image guided biopsy
- Women between ages 40-74 with dense breasts having a mammogram
- Women identified as having an average or intermediate risk of breast cancer (defined as 10- 20% lifetime risk based on a clinical risk model).
Exclusion
- Women with metallic implants
- Women that are claustrophobic
- Women that have a fear of needles or contrast
- Women that have had an allergic reaction to contrast in the past
- Women that are pregnant
- Women who are demonstrated to be at risk for an allergic reaction or nephrogenic systemic fibrosis (NSF)
Key Trial Info
Start Date :
September 17 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 14 2024
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04877912
Start Date
September 17 2020
End Date
September 14 2024
Last Update
May 6 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Chicago Mitchell Hospital
Chicago, Illinois, United States, 60637